Fairman Group »

Vistagen Therapeutics Ord shares owned by Fairman Group

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Fairman Group from 13F filings

Historical chart of Fairman Group investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Fairman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Fairman Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $87 29 3.00
2024-06-30 $101 29 3.48
2024-03-31 $153 29 5.28
2023-12-31 $148 29 5.14

More positions owned by Fairman Group

Accenture Plc Ireland Shs Class A (ACN)
Ishares Tr Core S&p500 Etf (IVV)
Essent (ESNT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Veeva Sys Cl A Com (VEEV)
Accolade (ACCD)
W.R. Berkley Corporation (WRB)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Eafe Etf (EFA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)

View all positions for Fairman Group

Top funds holding Vistagen Therapeutics Ord

BVF
Stempoint Capital
Vanguard Group
Commodore Capital
Nantahala Capital Management
Sphera Funds Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
BlackRock
Citadel Advisors
Armistice Capital
Geode Capital Management
Susquehanna International
Renaissance Technologies
Goldman Sachs Group

View all funds holding Vistagen Therapeutics Ord